SRI International, Menlo Park, CA, United States.
Front Public Health. 2024 Mar 12;12:1349552. doi: 10.3389/fpubh.2024.1349552. eCollection 2024.
Mouse models of radiation injury are critical to the development of medical countermeasures (MCMs) against radiation. Now that MCMs against hematopoietic acute radiation syndrome (H-ARS) have achieved regulatory approval, attention is shifting to develop MCMs against the adverse effects of gastrointestinal acute radiation syndrome (GI-ARS) and delayed effects of acute radiation exposure (DEARE). The C57L/J mouse model of partial body irradiation (PBI) with 2.5% bone marrow shielding (BM2.5) is being leveraged to examine both GI-ARS and DEARE effects. Within days of PBI, mice may develop H- and GI-ARS followed several months later by DEARE as a multi-organ injury, which typically involves the lung and kidney (L- and K-DEARE, respectively). The objective of this manuscript is to describe the dose response relationship and progression of radiation injury in the C57L/J mouse and to evaluate its suitability for use in DEARE MCM testing.
In two separate studies conducted over 2 years, male and female C57L/J mice were exposed to PBI BM2.5 with one hindlimb shielded from radiation, representing ~2.5% bone marrow shielding/sparing. Mice were X-ray irradiated at doses ranging from 9 to 13 Gy at 10 to 12 weeks of age for the purposes of assessing ARS survival at 30 days and DEARE survival at 182 days post-irradiation. Clinical indicators of ARS and DEARE were determined by clinical observations, body weights, hematology, clinical chemistry, magnetic resonance imaging (MRI) of lung, and histopathology of selected tissues.
C57L/J mice developed canonical ARS responses of hematopoietic atrophy and gastrointestinal injury resulting in dose dependent mortality at doses ≥11 Gy between 1- and 15-days post-irradiation. In animals that survived ARS, DEARE associated mortality occurred in dose dependent fashion at ≥9 Gy for both sexes between 60- and 159-days post-irradiation with histopathology examinations indicating lung injury as the primary cause of death in moribund animals.
The PBI BM2.5 C57L/J mouse model reliably produced known H- and GI-ARS effects at doses greater than those resulting in DEARE effects. Because of this, the C57L/J mouse can be used to test MCMs against L-DEARE injury, while avoiding ARS associated mortality.
辐射损伤的小鼠模型对于辐射医学对策(MCM)的发展至关重要。既然针对造血急性辐射综合征(H-ARS)的 MCM 已获得监管批准,那么人们的注意力正在转移到开发针对胃肠道急性辐射综合征(GI-ARS)和急性辐射暴露延迟效应(DEARE)的 MCM 上。利用 2.5%骨髓屏蔽(BM2.5)的 C57L/J 小鼠部分身体照射(PBI)模型来检查 GI-ARS 和 DEARE 效应。在 PBI 后的几天内,小鼠可能会出现 H-和 GI-ARS,随后几个月后会出现多器官损伤的 DEARE,通常涉及肺和肾(分别为 L-和 K-DEARE)。本文的目的是描述 C57L/J 小鼠的辐射损伤剂量反应关系和进展,并评估其在 DEARE MCM 测试中的适用性。
在两年内进行的两项独立研究中,雄性和雌性 C57L/J 小鼠接受了 PBI BM2.5,其中一条后腿受到辐射屏蔽,代表约 2.5%的骨髓屏蔽/保留。10 至 12 周龄时,将小鼠 X 射线照射,剂量范围为 9 至 13 Gy,目的是评估 30 天内 ARS 存活率和 182 天后 DEARE 存活率。通过临床观察、体重、血液学、临床化学、肺磁共振成像(MRI)和选定组织的组织病理学来确定 ARS 和 DEARE 的临床指标。
C57L/J 小鼠表现出典型的 ARS 反应,包括造血萎缩和胃肠道损伤,导致 1-15 天内剂量依赖性死亡率,剂量≥11 Gy。在存活 ARS 的动物中,9 至 13 Gy 剂量之间,雌雄动物均以剂量依赖性方式发生 DEARE 相关死亡率,60 至 159 天内,组织病理学检查表明肺损伤是濒死动物死亡的主要原因。
PBI BM2.5 C57L/J 小鼠模型在大于产生 DEARE 效应的剂量下可靠地产生了已知的 H-和 GI-ARS 效应。因此,C57L/J 小鼠可用于测试针对 L-DEARE 损伤的 MCM,同时避免 ARS 相关死亡率。